Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells-Reference-Cited by-同舟云学术

Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells

Published:2003-02 Issue:2 Volume:61 Page:468-473
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Fechner G,Perabo F.G.E,Schmidt D.H,Haase L,Ludwig E,Schueller H,Blatter J,Mller S.C,Albers P

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Current perspectives in muscle invasive bladder cancer;Sternberg;Eur J Cancer,2002

2. Von der Maase H: Current and future perspectives in advanced bladder cancer: is there a new standard? Semin Oncol 29 (1 suppl 3): 3–14, 2002

3. Organ preservation in patients with invasive bladder cancer;Rodel;Int J Radiat Oncol Biol Phys,2002

4. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (gemcitabine);Lawrence;Clin Cancer Res,1997

5. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines;Mose;Anticancer Res,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives;Cancers;2020-12-30

2. Significance of TP53 mutation in bladder cancer disease progression and drug selection;PeerJ;2019-12-16

3. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation;Pathology & Oncology Research;2017-06-02

4. Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes;Molecular Biology Reports;2012-10-09

5. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells;Cytokine;2012-08